azimexon has been researched along with Benign Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hadden, JW | 1 |
Wybran, J | 1 |
Mathé, G; Reizenstein, P | 1 |
Mathe, G | 1 |
Bonardelle, D; Goutner, A; Nasrat, F; Rameau, G | 1 |
Claghorn, L; Hersh, EM; Mavligit, G; Patt, YZ; Reuben, J | 1 |
2 review(s) available for azimexon and Benign Neoplasms
Article | Year |
---|---|
Biological response modifiers and differentiation inducers. Current status in cancer research.
Topics: Adjuvants, Immunologic; Aziridines; Bacterial Vaccines; Cell Differentiation; Cyclosporins; Dimethyl Sulfoxide; Glucans; Hormones; Humans; Leucine; Levamisole; Lithium; Neoplasms; Peptides; Retinoids; Selenium | 1983 |
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin | 1980 |
4 other study(ies) available for azimexon and Benign Neoplasms
Article | Year |
---|---|
Chemically defined immunotherapeutic agents.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin | 1983 |
The immunopharmacology of synthetic immunomodulators.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Ditiocarb; Glucans; Humans; Hypoxanthines; Immunity; Inosine Pranobex; Interferon Inducers; Leucine; Levamisole; Lynestrenol; Neoplasms | 1983 |
Immunorestoration of anergic cancer patients by azimexon.
Topics: Adjuvants, Immunologic; Aziridines; Azirines; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphocytes; Neoplasms; Tetradecanoylphorbol Acetate | 1980 |
A phase I study of intravenous azimexon therapy in human cancer.
Topics: Adjuvants, Immunologic; Aziridines; Azirines; Drug Evaluation; Humans; Leukocyte Count; Lymphocyte Activation; Melanoma; Mitogens; Neoplasms; T-Lymphocytes | 1986 |